Ser552
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Phosphorylation Site Page:
Ser552 - CTNNB1 (mouse)

Site Information
QDTQRRtsMGGtQQQ   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: CTNNB1 (human): S552, CTNNB1 (rat): S552
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 472273

In vivo Characterization
Methods used to characterize site in vivo: immunoprecipitation (20), mass spectrometry (1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 17, 18, 19, 21), microscopy-colocalization with upstream kinase (13), phospho-antibody (13, 15, 16, 20), western blotting (15, 16)
Disease tissue studied: anthrax infection (12), melanoma skin cancer (19), Cowden disease (20)
Relevant cell line - cell type - tissue: '3T3-L1, differentiated' (adipocyte) (2, 5), 'brain, cerebral cortex' (16, 18), brain (9, 14), epithelial (15), epithelial [PIK3R1 (mouse), homozygous knockout] (13), heart (6), intestine (20), liver (4, 8, 21), liver [leptin (mouse), homozygous knockout] (8), MC3T3-E1 (preosteoblast) (1), MEF (fibroblast) (7, 11), MEF (fibroblast) [p53 (mouse), homozygous knockout] (10), MEF (fibroblast) [TSC2 (mouse), homozygous knockout] (11), mpkCCD (renal) (17), skin [mGluR1 (mouse), transgenic, TG mutant mice] (19), spleen (12)

Controlled by
Regulatory protein: IFNG (mouse) (15), PIK3R1 (mouse) (13), PTEN (mouse) (20)
Putative upstream kinases: Akt1 (mouse) (16)
Kinases, in vitro: Akt1 (human) (20)
Treatments: anti-CD3 (13), IL-22 (15), IL-6 (15), inflammation (15), LY294002 (13), piroxicam (13), PTH(1-34) (1), triciribine (15, 16)

Downstream Regulation
Effects of modification on CTNNB1: intracellular localization (20)
Effects of modification on biological processes: transcription, altered (16)

Disease / Diagnostics Relevance
Relevant diseases: Cowden disease (20)

References

1

Williams GR, et al. (2016) Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomics. Methods 92, 36-50
26160508   Curated Info

2

Parker BL, et al. (2015) Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry. Sci Signal 8, rs6
26060331   Curated Info

3

Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704
24719451   Curated Info

4

Wilson-Grady JT, Haas W, Gygi SP (2013) Quantitative comparison of the fasted and re-fed mouse liver phosphoproteomes using lower pH reductive dimethylation. Methods 61, 277-86
23567750   Curated Info

5

Humphrey SJ, et al. (2013) Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2. Cell Metab 17, 1009-20
23684622   Curated Info

6

Lundby A, et al. (2013) In vivo phosphoproteomics analysis reveals the cardiac targets of β-adrenergic receptor signaling. Sci Signal 6, rs11
23737553   Curated Info

7

Wu X, et al. (2012) Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics. Mol Cell Proteomics 11, 1640-51
22942356   Curated Info

8

Grimsrud PA, et al. (2012) A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis. Cell Metab 16, 672-83
23140645   Curated Info

9

Goswami T, et al. (2012) Comparative phosphoproteomic analysis of neonatal and adult murine brain. Proteomics 12, 2185-9
22807455   Curated Info

10

Hsu PP, et al. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-22
21659604   Curated Info

11

Yu Y, et al. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-6
21659605   Curated Info

12

Manes NP, et al. (2011) Discovery of mouse spleen signaling responses to anthrax using label-free quantitative phosphoproteomics via mass spectrometry. Mol Cell Proteomics 10, M110.000927
21189417   Curated Info

13

Lee G, et al. (2010) Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology 139, 869-81, 881.e1-9
20580720   Curated Info

14

Wiśniewski JR, et al. (2010) Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J Proteome Res 9, 3280-9
20415495   Curated Info

15

Nava P, et al. (2010) Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity 32, 392-402
20303298   Curated Info

16

Zhang J, et al. (2010) Cortical neural precursors inhibit their own differentiation via N-cadherin maintenance of beta-catenin signaling. Dev Cell 18, 472-9
20230753   Curated Info

17

Rinschen MM, et al. (2010) Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells. Proc Natl Acad Sci U S A 107, 3882-7
20139300   Curated Info

18

Tweedie-Cullen RY, Reck JM, Mansuy IM (2009) Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J Proteome Res 8, 4966-82
19737024   Curated Info

19

Zanivan S, et al. (2008) Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. J Proteome Res 7, 5314-26
19367708   Curated Info

20

He XC, et al. (2007) PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 39, 189-98
17237784   Curated Info

21

Villén J, Beausoleil SA, Gerber SA, Gygi SP (2007) Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A 104, 1488-93
17242355   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.